Safety, Efficacy, and Pharmacokinetics of Amphotericin B Lipid Complex

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2007
The purpose of this study is to determine if initial therapy with ABLC at 10/mg/kg/d for 7 days are at least effective as ABLC at 5.0 mg/kg/d X 14 days as induction treatment of patients with disseminated cryptococcosis and HIV.
Epistemonikos ID: 413e13fceb980106c0ea855f4e333554d3217511
First added on: May 11, 2024